Phosphoproteomics in translational research: a sarcoma perspective.
about
Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib.Exploiting receptor tyrosine kinase co-activation for cancer therapy.Advances in mass spectrometry based strategies to study receptor tyrosine kinases.Integrating phosphoproteomics into the clinical management of prostate cancerTargeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy.Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance
P2860
Phosphoproteomics in translational research: a sarcoma perspective.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Phosphoproteomics in translational research: a sarcoma perspective.
@en
type
label
Phosphoproteomics in translational research: a sarcoma perspective.
@en
prefLabel
Phosphoproteomics in translational research: a sarcoma perspective.
@en
P2093
P2860
P356
P1433
P1476
Phosphoproteomics in translational research: a sarcoma perspective
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDW030
P577
2016-01-22T00:00:00Z